Jingshi Wang

Jingshi Wang

Auto-generated profile, based on publicly available information

Jingshi Wang

Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2024 in Blood
Verified
Journal Article
Closed access
PDF file
JWJingshi Wang
Jingshi Wang
MSMin Su
Min Su
NWNa Wei
Na Wei
HYHuanyu Yan
Huanyu Yan
JZJia Zhang
Jia Zhang
ZWZhao Wang
Zhao Wang
Chronic active Epstein-Barr virus (EBV) disease (CAEBV) is a lethal syndrome because of persistent EBV infection. When diagnosed as CAEBV, EBV infection was observed in multiple hematopoietic lineages, but the etiology of CAEBV is still elusive. Bone marrow and peripheral cells derived from 5 patients with CAEBV, 1 patient with EBV-associated hemophagocytic lymphohistiocytosis, and 2 healthy controls were analyzed. Multiple assays were applied to identify and characterize EBV-infected cells, including quantitative polymerase chain reaction, PrimeFlow, and single-cell RNA-sequencing (scRNA-seq). Based on scRNA-seq data, alterations in gene expression of particular cell types were analyzed between patients with CAEBV and controls, and between infected and uninfected cells. One patient with CAEBV was treated with allogeneic hematopoietic stem cell transplantation (HSCT), and the samples derived from this patient were analyzed again 6 months after HSCT. EBV infected the full spectrum of the hematopoietic system including both lymphoid and myeloid lineages, as well as the hematopoietic stem cells (HSCs) of the patients with CAEBV. EBV-infected HSCs exhibited a higher differentiation rate toward downstream lineages, and the EBV infection had an impact on both the innate and adaptive immunity, resulting in inflammatory symptoms. EBV-infected cells were thoroughly removed from the hematopoietic system after HSCT. Taken together, multiple lines of evidence presented in this study suggest that CAEBV disease originates from the infected HSCs, which might potentially lead to innovative therapy strategies for CAEBV.

9 February 2021 in British Journal of Haematology
Verified
Journal Article
Closed access
PDF file
JWJingshi Wang
Jingshi Wang
RZRui Zhang
Rui Zhang
XWXiaoyan Wu
Xiaoyan Wu
FLFei Li
Fei Li
HYHaixia Yang
Haixia Yang
ZWZhao Wang
Zhao Wang